Merck CR`s Net Margin reached 2.78 % in 2017. This is 21.9 % more than in the previous year.
Buy annual subscriptions for all our products.
Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
Amgen Czech Republic | % | ... | ... | ... | ... | ... | 10.9 | 6.81 | 6.14 | 6.36 | 5.93 | ||||||||
Bayer Czech Republic | % | ... | ... | ... | 4.96 | 2.57 | 2.80 | 2.64 | 2.89 | ||||||||||
GlaxoSmithKline Czech Republic | % | ... | ... | ... | 4.12 | 2.86 | 2.25 | 1.81 | 2.85 | ||||||||||
Merck Czech Republic | % | ... | ... | 3.04 | 3.62 | 1.59 | 1.94 | 3.71 | |||||||||||
Novartis Czech Republic | % | 1.05 | 1.27 | 1.29 | 1.75 | 1.53 | |||||||||||||
Pfizer Czech Republic | % | ... | ... | 3.40 | 1.54 | 2.67 | 2.70 | 2.41 | |||||||||||
Roche Czech Republic | % | ... | ... | ... | 1.01 | 0.794 | 2.73 | 2.17 | 0.936 | ... | |||||||||
Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 0.782 | 0.626 | 0.998 | 0.019 | 0.889 | |||||||||
Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 3.85 | 3.94 | 3.09 | 2.41 | ||
Walmark | % | ... | ... | ... | 9.83 | -0.140 | -0.444 | 1.82 | -58.0 |